Table 3.
Variable * | n | 3Y LRPFS (%) | p † | 3Y PFS (%) | p † | 3Y OS (%) | p † | |
---|---|---|---|---|---|---|---|---|
Sex | Male | 137 | 41.6 | 0.251 | 22.9 | 0.589 | 36.6 | 0.017 |
Female | 20 | 63.3 | 23.8 | 55.0 | ||||
Age | ≤ 60 y | 65 | 41.3 | 0.563 | 20.5 | 0.444 | 35.5 | 0.307 |
> 60 y | 92 | 47.9 | 25.0 | 37.1 | ||||
ECOG | 0 | 39 | 32.6 | 0.611 | 15.0 | 0.318 | 34.4 | 0.721 |
1-2 | 118 | 47.8 | 25.5 | 36.8 | ||||
Histology | SqCC | 86 | 36.0 | 0.048 | 24.0 | 0.517 | 32.0 | 0.151 |
Others | 71 | 56.3 | 19.2 | 41.8 | ||||
ADC | 52 | 52.5 | 0.110 | 19.2 | 0.596 | 45.0 | 0.335 | |
Others | 105 | 40.5 | 24.9 | 34.6 | ||||
T stage | 1-2 | 79 | 56.4 | 0.034 | 25.2 | 0.281 | 43.8 | 0.106 |
3-4 | 78 | 33.8 | 20.7 | 28.7 | ||||
N stage | 0-2 | 81 | 49.4 | 0.448 | 29.2 | 0.108 | 37.0 | 0.686 |
3 | 76 | 39.5 | 17.0 | 35.6 | ||||
Stage | IIIA | 49 | 56.5 | 0.084 | 33.1 | 0.041 | 42.0 | 0.705 |
IIIB | 108 | 39.8 | 18.6 | 33.7 | ||||
GTVpre | (Continuous) | (95% CI) | (1.001) | (0.330) | (1.003) | (<0.001) | (1.001) | (0.019) |
(HR) | (0.999–1.002) | (1.002–1.004) | (1.000–1.002) | |||||
≤ 50 cm3 | 33 | 75.0 | 0.001 | 42.5 | 0.001 | 65.7 | < 0.001 | |
> 50 cm3 | 124 | 34.8 | 17.1 | 28.4 | ||||
GTVpost | (Continuous) | (95% CI) | (1.004) | (0.189) | (1.015) | (<0.001) | (1.006) | (0.008) |
(HR) | (0.998–1.010) | (1.008–1.021) | (1.002–1.011) | |||||
≤ 20 cm3 | 68 | 53.3 | 0.165 | 32.4 | 0.004 | 43.2 | 0.015 | |
> 20 cm3 | 89 | 36.7 | 15.5 | 31.0 | ||||
VRR | (Continuous) | (95% CI) | (1.011) | (0.126) | (1.008) | (0.139) | (1.013) | (0.028) |
(HR) | (0.997–1.025) | (0.997–1.020) | (1.001–1.025) | |||||
≤ 50% | 21 | 68.2 | 0.042 | 39.6 | 0.054 | 64.6 | 0.004 | |
>50% | 136 | 40.6 | 20.2 | 32.2 |
Abbreviations: ADC Adenocarcinoma, CI Confidence interval, ECOG Eastern Cooperative Oncology Group, GTV pre Initial gross tumor volume, GTV post Follow-up gross tumor volume, HR Harzard ratio, LRPFS locoregional progression-free survival rate, OS Overall survival rate, SqCC Squamous cell carcinoma, VRR Reduction ratio of gross tumor volume.
*All variables are categorical, unless being noted as “continuous”.
†The log-rank test and the Cox proportional hazards model were used for categorical and continuous variables, respectively.